Page 5 - Aurinia Pharmaceutical News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aurinia pharmaceutical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aurinia Pharmaceutical Today - Breaking & Trending Today

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Expected to Post Earnings of -$0.22 Per Share

Wall Street analysts predict that Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Get Rating) (TSE:AUP) will announce ($0.22) earnings per share for the current fiscal quarter, Zacks reports. Five analysts have provided estimates for Aurinia Pharmaceuticals’ earnings. The highest EPS estimate is ($0.19) and the lowest is ($0.25). Aurinia Pharmaceuticals posted earnings of ($0.37) per share during […] ....

United States , Morgan Stanley , Aurinia Pharmaceuticals Inc , Zacks Investment Research , Blackrock Inc , Renaissance Technologies , Aurinia Pharmaceuticals Get Rating , Bellevue Group , Cantor Fitzgerald , Aurinia Pharmaceuticals , Citigroup Inc , Wall Street , Get Rating , Aurinia Pharmaceutical , Investment Research , Pharmaceuticals Inc , Nasdaq Auph ,

-$0.24 Earnings Per Share Expected for Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) This Quarter

Wall Street analysts predict that Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Get Rating) (TSE:AUP) will post earnings of ($0.24) per share for the current fiscal quarter, Zacks reports. Five analysts have provided estimates for Aurinia Pharmaceuticals’ earnings. The highest EPS estimate is ($0.23) and the lowest is ($0.24). Aurinia Pharmaceuticals reported earnings of ($0.40) per share […] ....

United States , Selective Wealth Management Inc , Aurinia Pharmaceuticals Inc , Zacks Investment Research , Aurinia Pharmaceuticals Get Rating , Lazard Asset Management , Geneos Wealth Management Inc , Jefferies Financial Group , Cantor Fitzgerald , Aurinia Pharmaceuticals , Macquarie Group Ltd , Wall Street , Get Rating , Aurinia Pharmaceutical , Investment Research , Wealth Management , Pharmaceuticals Inc , Nasdaq Auph ,